Theta Burst Stimulation for Brain Connectivity Changes
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to understand how Theta Burst Stimulation (TBS), a type of brain stimulation, affects brain connections. Researchers use this technique to determine if changes in brain connectivity can predict improvements in mental health symptoms. Participants will receive either intermittent or continuous TBS, a form of non-invasive brain stimulation, to study these effects. The trial seeks right-handed individuals without significant medical or psychiatric conditions, recent struggles with alcohol or drugs, or metal implants that would interfere with MRI scans. As an unphased trial, this study offers participants the chance to contribute to groundbreaking research that could enhance mental health treatments.
Will I have to stop taking my current medications?
The trial excludes participants who are taking medications that act on the central nervous system, so you may need to stop taking such medications to participate.
What prior data suggests that this technique is safe?
Research has shown that continuous theta burst stimulation (cTBS) is generally safe and well-tolerated. Studies indicate that cTBS does not increase unexpected or harmful effects, making it a safe option for treating various conditions.
Intermittent theta burst stimulation (iTBS) is also considered safe. In 2018, the FDA approved iTBS for treating major depression, confirming that it meets safety standards for this purpose. However, while iTBS is effective, its safety profile limits its use for longer or more intense sessions.
Both cTBS and iTBS typically do not cause serious side effects. They are well-tolerated, allowing most people to undergo these treatments without major issues.12345Why are researchers excited about this trial?
Researchers are excited about theta burst stimulation (TBS) because it offers a new way to influence brain connectivity, which is crucial for treating various neurological conditions. Unlike traditional treatments that may rely on medications or invasive procedures, TBS uses a non-invasive magnetic coil to deliver short bursts of stimulation to the brain, potentially leading to faster and more targeted effects. Additionally, the trial explores two different protocols, continuous (cTBS) and intermittent (iTBS), which might offer flexibility in treatment plans depending on individual patient needs. This approach could revolutionize how we enhance brain function with fewer side effects than current options.
What evidence suggests that this trial's treatments could be effective for brain connectivity changes?
Research has shown that Intermittent Theta Burst Stimulation (iTBS), one of the treatments in this trial, can quickly and effectively improve depression symptoms, particularly in teenagers. Studies suggest that iTBS alters brain activity, potentially aiding in the treatment of other conditions. Continuous Theta Burst Stimulation (cTBS), another treatment arm in this trial, has been shown to change how different parts of the brain connect and improve certain mental health symptoms, such as hearing voices. Both iTBS and cTBS appear to affect brain networks, which is why researchers are studying them for mental health treatments in this trial. These findings suggest that both types of stimulation could enhance brain function and alleviate mental health symptoms.26789
Who Is on the Research Team?
Nicholas L Balderston
Principal Investigator
University of Pennsylvania
Are You a Good Fit for This Trial?
This trial is for right-handed individuals who can consent to participate. It's not suitable for those with recent alcohol/drug issues, medical conditions affecting fMRI or TMS safety, metal implants, claustrophobia, severe psychiatric disorders, epilepsy, pregnancy, non-English speakers, CNS medications use or any significant health problems.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive multiple doses of either intermittent or continuous theta burst stimulation (iTBS and cTBS) over 3 stimulation days, with 5 sessions per day.
Follow-up
Participants are monitored for changes in resting state functional connectivity and working memory performance 24 hours after each dose.
What Are the Treatments Tested in This Trial?
Interventions
- Continuous Theta Burst Stimulation
- Intermittent Theta Burst Stimulation
Find a Clinic Near You
Who Is Running the Clinical Trial?
Nicholas Balderston, PhD
Lead Sponsor